3347 — Hangzhou Tigermed Consulting Co Balance Sheet
0.000.00%
- HK$36.77bn
- HK$40.56bn
- CNY6.83bn
Annual balance sheet for Hangzhou Tigermed Consulting Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | CAS | CAS | CAS | CAS | CAS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 8,408 | 7,808 | 7,483 | 2,138 | 1,782 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 2,177 | 3,123 | 3,734 | 3,996 | 4,150 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 10,852 | 11,107 | 11,344 | 6,300 | 6,177 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 1,142 | 1,340 | 1,486 | 1,696 | 1,727 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 23,741 | 27,447 | 29,681 | 28,671 | 28,359 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 2,413 | 3,730 | 4,139 | 3,662 | 2,835 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 5,618 | 7,863 | 8,654 | 8,000 | 7,399 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Unrealized Gain / Loss | |||||
| Other Equity | |||||
| Total Equity | 18,124 | 19,583 | 21,027 | 20,671 | 20,960 |
| Total Liabilities & Shareholders' Equity | 23,741 | 27,447 | 29,681 | 28,671 | 28,359 |
| Total Common Shares Outstanding |